Back to UBS Group AG UBS Group AG

TXMDTXMD
Showing 8 of 17 quarters

Position history for UBS Group AGUBS Group AG's holdings in THERAPEUTICSMD INC

UBS Group AG holds 4,660 shares of TXMD (THERAPEUTICSMD INC), worth $10,299 as of 2026-Q2. The position was increased (+1307.8% shares).

Current Value

$10,299

Current Shares

4,660

Total Value Change

+$2,253

Total Shares Change

-187

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4,660
+1307.8%
$10,2990.0%$2.21
19
2026-Q1
Decreased
331
-70.3%
$6690.0%$2.22
0
2025-Q4
Increased
1,114
+207.7%
$1,8150.0%$1.64
12
2025-Q3
Decreased
362
-92.0%
$3900.0%$1.08
0
2025-Q2
Increased
4,502
+2472.6%
$5,2220.0%$1.12
17
2025-Q1
Decreased
175
-91.3%
$1620.0%$0.98
0
2024-Q4
Decreased
2,012
-58.5%
$1,7300.0%$1.03
0
2024-Q3
Decreased
4,847
-46.8%
$8,0460.0%$1.64
0

Other major holders of TXMD: VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used